LPC
Lion Point Capital Portfolio holdings
AUM
$14.7M
This Quarter Return
+4.86%
1 Year Return
+16.78%
3 Year Return
+52.25%
5 Year Return
+189.95%
10 Year Return
–
AUM
$24.9M
AUM Growth
+$24.9M
(-22%)
Cap. Flow
-$8.97M
Cap. Flow
% of AUM
-35.99%
Top 10 Holdings %
Top 10 Hldgs %
78.38%
Holding
31
New
4
Increased
3
Reduced
8
Closed
5
Top Buys
| 1 |
Biohaven
BHVN
|
$1.77M |
| 2 |
BLUE
bluebird bio
BLUE
|
$468K |
| 3 |
Disc Medicine
IRON
|
$378K |
| 4 |
Benitec Biopharma
BNTC
|
$358K |
| 5 |
Arcutis Biotherapeutics
ARQT
|
$326K |
Top Sells
| 1 |
Ardelyx
ARDX
|
$3.35M |
| 2 |
MRNS
Marinus Pharmaceuticals, Inc
MRNS
|
$2.5M |
| 3 |
Insmed
INSM
|
$1.32M |
| 4 |
Neurocrine Biosciences
NBIX
|
$1.15M |
| 5 |
Kiniksa Pharmaceuticals
KNSA
|
$1.08M |
Sector Composition
| 1 | Healthcare | 94.86% |
| 2 | Technology | 0.17% |
| 3 | Communication Services | 0.07% |
| 4 | Consumer Discretionary | 0% |
| 5 | Energy | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Mirum Pharmaceuticals
MIRM
$3.71B
| – | – |
0
| – | – |
|
|
27
Neurocrine Biosciences
NBIX
$13.8B
| – | – |
-8,350
| Closed | -$1.15M |
|
28
SPDR S&P Biotech ETF
XBI
$5.07B
| – | – |
0
| – | – |
|
|
BFIIW
29
DELISTED
BurgerFi International, Inc. Warrant
BFIIW
| – | – |
-2,083,438
| Closed | -$26.3K |
|
|
BFI
30
DELISTED
BurgerFi International, Inc. Common Stock
BFI
| – | – |
-2,745,938
| Closed | -$557K |
|
|
NFYS
31
DELISTED
Enphys Acquisition Corp.
NFYS
| – | – |
-78,125
| Closed | -$858K |
|